Dr Batra’s® Unveils Cutting-Edge XOGEN Therapy in Chennai: A First-of-Its-Kind Exosome-Based Solution for Hereditary Hair Loss


Chennai, 26th September, 2024: Dr Batra's® Healthcare, the world's largest chain of homeopathic clinics, today introduced India’s first and world’s most advanced exosome-based targeted hair treatment - XOGEN in Chennai, designed to combat hereditary hair loss in both men and women. The new treatment was unveiled during a press conference held in the city and aims to solve hereditary hair loss using potent formulation and is clinically proven to show visible results in just three months. This cutting-edge innovative treatment represents the next generation of regenerative aesthetics and introduces the most advanced solution in the field of hair restoration and cellular regeneration.

Dr Batra’s® Unveils Cutting-Edge XOGEN Therapy in Chennai: A First-of-Its-Kind Exosome-Based Solution for Hereditary Hair Loss
Dr. Akshay Batra, Vice-Chairman and Managing Director of Dr Batra’s® Healthcare 
XOGEN’s exosome therapy offers a natural and state-of-the-art approach to hair loss, elevating the science and safety of hair restoration. Exosomes, which play a vital role in regulating various cellular processes, serve as the foundation of this treatment. The process begins with the release of growth factor-rich exosomes, which migrate to targeted areas of the scalp, where they locate and latch onto damaged hair cells. Upon absorption into the hair follicles, the exosomes activate hair follicle stem cells and promote cellular regeneration.

Press meet Youtube Video 👇 

Commenting on the occasion, Dr. Akshay Batra, Vice-Chairman and Managing Director of Dr Batra’s® Healthcare and the first Indian President of The Trichological Society of London (UK), said, “Hair loss issue has become a critical issue in India across both men and women, leading to social stigma, loss of confidence, depression etc. Some studies indicate that the onset of pattern baldness has decreased to 21 years while another study indicates 50% men and 22% women suffer from pattern baldness respectively which is alarming. To address this issue, we are excited to introduce XOGEN, a ground-breaking treatment that represents the future of hair restoration.

 Exosome therapy is a cutting-edge innovation that harnesses the power of regenerative science to offer our patients a safe, natural, and highly effective solution for hereditary hair loss. At Dr Batra’s®, we are committed to combining the best of science with holistic care, and XOGEN is a testament to that vision.”The event was graced by Managing Director and Trichologist, Dr. Akshay Batra along Mr. Sanjoy Mukerji, Group CEO and Dr. Mathu Venkatesh senior mentor at Dr Batra’s® Group of Companies.

The exosome-based formulation found in XOGEN is designed to regulate immune responses, reduce inflammation, and create an environment conducive to healthy hair growth. Additionally, exosomes help stimulate the formation of new blood vessels, a process known as angiogenesis, which enhances blood flow and nutrient supply to the hair follicles, further supporting hair growth.

Dr Batra's® Healthcare, known for its commitment to integrating science with natural treatments, continues to lead the industry with this latest advancement. XOGEN reflects the brand’s vision to offer innovative and safe solutions for hereditary hair loss, while promoting long-term hair health.

****

Popular posts from this blog

𝘒𝘢𝘶𝘷𝘦𝘳𝘺 𝘏𝘰𝘴𝘱𝘪𝘵𝘢𝘭, 𝘙𝘢𝘥𝘪𝘢𝘭 𝘙𝘰𝘢𝘥, 𝘓𝘢𝘶𝘯𝘤𝘩𝘦𝘴 𝘈𝘐 𝘚𝘱𝘦𝘤𝘪𝘢𝘭𝘪𝘴𝘦𝘥 𝘊𝘭𝘪𝘯𝘪𝘤𝘴 𝘪𝘯 𝘕𝘦𝘶𝘳𝘰𝘭𝘰𝘨𝘺 𝘢𝘯𝘥 𝘉𝘳𝘢𝘪𝘯 & 𝘚𝘱𝘪𝘯𝘦 𝘚𝘶𝘳𝘨𝘦𝘳𝘺

𝘚𝘢𝘣𝘴𝘦 𝘗𝘦𝘩𝘭𝘦 𝘓𝘪𝘧𝘦 𝘐𝘯𝘴𝘶𝘳𝘢𝘯𝘤𝘦 𝘊𝘢𝘮𝘱𝘢𝘪𝘨𝘯 & 𝘔𝘢𝘳𝘬𝘦𝘵 𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩 𝘣𝘺 𝘐𝘯𝘴𝘶𝘳𝘢𝘯𝘤𝘦 𝘈𝘸𝘢𝘳𝘦𝘯𝘦𝘴𝘴 𝘊𝘰𝘮𝘮𝘪𝘵𝘵𝘦𝘦 (𝘐𝘈𝘊-𝘓𝘪𝘧𝘦)

𝘉𝘢𝘯𝘬 𝘰𝘧 𝘐𝘯𝘥𝘪𝘢 𝘊𝘩𝘦𝘯𝘯𝘢𝘪 𝘡𝘰𝘯𝘦 𝘰𝘳𝘨𝘢𝘯𝘪𝘴𝘦𝘴 𝘜𝘥𝘺𝘢𝘮𝘪 𝘝𝘪𝘬𝘢𝘴 𝘜𝘵𝘴𝘢𝘷; 𝘌𝘹𝘱𝘰𝘳𝘵 & 𝘔𝘚𝘔𝘌 𝘊𝘶𝘴𝘵𝘰𝘮𝘦𝘳 𝘖𝘶𝘵𝘳𝘦𝘢𝘤𝘩 𝘗𝘳𝘰𝘨𝘳𝘢𝘮

𝘚𝘐𝘔𝘚 𝘏𝘰𝘴𝘱𝘪𝘵𝘢𝘭 𝘚𝘶𝘤𝘤𝘦𝘴𝘴𝘧𝘶𝘭𝘭𝘺 𝘛𝘳𝘦𝘢𝘵𝘴 𝘙𝘢𝘳𝘦 𝘚𝘬𝘪𝘯 𝘛𝘶𝘮𝘰𝘶𝘳 𝘸𝘪𝘵𝘩 𝘚𝘬𝘶𝘭𝘭 & 𝘚𝘤𝘢𝘭𝘱 𝘙𝘦𝘤𝘰𝘯𝘴𝘵𝘳𝘶𝘤𝘵𝘪𝘰𝘯

𝘕𝘢𝘷𝘪𝘯’𝘴 & 𝘈𝘶𝘮 𝘎𝘳𝘪𝘩𝘢 𝘓𝘓𝘗 𝘓𝘢𝘶𝘯𝘤𝘩 𝘓𝘶𝘹𝘶𝘳𝘺 𝘗𝘳𝘦𝘮𝘪𝘶𝘮 𝘈𝘱𝘢𝘳𝘵𝘮𝘦𝘯𝘵𝘴 𝘪𝘯 𝘊𝘰𝘭𝘭𝘦𝘨𝘦 𝘙𝘰𝘢𝘥; 𝘍𝘦𝘢𝘵𝘶𝘳𝘪𝘯𝘨 𝘣𝘦𝘴𝘱𝘰𝘬𝘦 𝘩𝘰𝘮𝘦𝘴 𝘢𝘤𝘳𝘰𝘴𝘴 9 𝘭𝘦𝘷𝘦𝘭𝘴